- Advertisement -

Related

Veritas Beats Peers on Hedge Fund Returns

- Advertisement -

Stockholm (HedgeNordic) – All four pension insurance companies in Finland – Elo, Ilmarinen, Varma, and Veritas – maintain a more sizeable share of their portfolios in hedge funds compared to several years ago. Their hedge fund portfolios delivered positive – yet very different – returns during 2022.

Ilmarinen’s hedge fund portfolio, which reached €4.8 billion at the end of 2022 or 8.6 percent of the overall portfolio, returned 8.2 percent last year to offset some of the broader portfolio’s losses (read more). Varma, which maintains the highest allocation to hedge funds among the four pension insurers, saw its hedge fund portfolio return 2.3 percent in 2022 after enjoying a 15.3 percent return in 2021. Varma had 15 percent of its portfolio allocated to hedge funds at the end of 2022, amounting to €8.4 billion in investments.

Elo, the third-largest of the four pension insurance companies in Finland’s private sector earnings-related pension system, saw its hedge fund portfolio return a similar 2.3 percent in 2022. Elo’s hedge fund investments accounted for 9.3 percent of its overall portfolio at the end of 2022, equivalent to €2.6 billion. The hedge fund portfolio of Veritas, the smallest of the four pension insurers, returned a more impressive 12.3 percent in 2022. Veritas had €337 million or 8.1 percent of the overall portfolio allocated to hedge funds at the end of last year.

“Alternative investments served as the bright spot of the year, with their positive development mitigating the negative return impact of the equity and fixed-income markets.”

Veritas’ bucket of “other investments,” more than half of which comprise hedge funds, garnered a 10.3 percent return in 2022. “Alternative investments served as the bright spot of the year, with their positive development mitigating the negative return impact of the equity and fixed-income markets,” says Kari Vatanen (pictured), CIO of Veritas. The Turku-headquartered pension provider’s fixed-income investments incurred a loss of 7.4 percent in 2022, equity investments experienced a loss of 8.4 percent, while real estate investments delivered a positive return of 3.3 percent and other investments returned 10.3 percent.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Systematic Multi-Strategy as a Portfolio Diversifier

By Fredrik Langenskiöld – Union Bancaire Privée: Multi-strategy funds are those that allocate to more than one alternative strategy or portfolio manager (PM) in...

Visio Allocator Delivers Record Month on AI Chip Rally

After a more muted, albeit still challenging, first quarter, multi-strategy fund Visio Allocator regained momentum starting in April and delivered its strongest month on...

Colosseum’s Difficult Stretch Continues as Co-Portfolio Manager Departs

After a volatile journey since launching in mid-2025, Colosseum Global Alpha has suffered two consecutive months of steep losses, leaving the fund down more...

CABA Offers Another Roll Down the Curve

CABA Capital has launched the fourth iteration of its Flex strategy, a three-year closed-ended AAA-yield premium strategy designed to harvest roll-down and pull-to-par effects...

Even Steven for Nordic CTAs in Mediocre May

May was another month characterized by reversals and cross-asset volatility. Strong momentum in U.S. equities contrasted with directionless moves across other markets, creating a...

Rhenman Doubles Down on Smaller Healthcare Innovators with New Fund

Many of healthcare’s most transformative breakthroughs often originate not from established industry giants, but from smaller companies developing new technologies, therapies, and treatment approaches....

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -